Bioclub 贝壳社

bioclub has broad resource network in china including 200,000+ entrepreneurs, 10,000+ startup companies, 500+ investment institutions, 1200+ investors, 1500+ industry kols, 100+ listed/unicorn companies. bioclub also manages rmb 400 million angels funds and has totally invested 35+ medical projects. in addition, bioclub’s shareholders are very influential in the industry including 3 founders of listed companies and 4 leading investment institutions in china. bioclub builds strategic partnership with astrazeneca, fosun pharm, china resources group, meinian health, bgi, china life insurance, taikang life insurance, lepu medical, tigermed, tasly, dean diagnostics, conba pharm, iflytek, cec data, century, pingan technology, andon medical，tellgen, uec group, deloitte, minsheng pharm, baheal pharm, babytree, cbt pharm, west china hospital, the first affiliated hospital of zhejiang university, the second affiliated hospital of zhejiang university, the eye hospital of wenzhou medical univer